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Abstract 
Objectives: Periodontitis and gingivitis remain two of the most common diseases that affect the oral 
cavity. As they are caused by plaque, effective oral hygiene, elimination of plaque-retentive factors 
and successful periodontal treatment will result in resolution of gingival and periodontal inflammation. 
Certain systemic diseases can have a clinical appearance similar to periodontal diseases or 
exacerbate existing periodontitis/gingivitis and vice versa. This paper aims to provide the dental 
practitioner with an understanding of the manifestation of systemic diseases to the periodontium and 
highlights elements in the clinical assessment, which will aid in establishing a correct diagnosis. 
Data sources: Additional anamnestic and clinical clues are important for distinguishing between 
plaque-induced and non plaque-induced lesions. The first part of this compendium covers immune-
mediated and hereditary conditions as causes of gingival lesions, which can resemble those caused 
by dental plaque. The different conditions are presented concisely and exemplified by clinical 
photographs. 
Conclusions: Dental practitioners should be aware of the various manifestations of systemic 
diseases to the periodontium in order to offer appropriate diagnosis and treatment, which can reduce 
both patient morbidity and mortality.  
 
 
 
Keywords: periodontitis, gingivitis, non plaque-induced inflammation, autoimmunity, hereditary 
diseases 
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Introduction 
Periodontitis is a complex inflammatory disease that affects the soft and hard periodontal structures 
(Figure 1a). It is a plaque related disease initiated by bacteria, and driven by the host response, 
genetic predisposition and environmental risk factors. Periodontits, if left untreated, often leads to 
progressive destruction of the tooth supporting tissues and tooth loss (1). Typical clinical findings are 
pocketing and/or gingival recession. Gingivitis on the other hand is characterised by redness and 
swelling of the keratinised gingiva adjacent to the teeth (Figure 1b). In plaque-induced gingivitis, these 
symptoms resolve after plaque control.  As opposed to periodontitis, gingivitis is therefore a reversible 
disease. There are, however, cases that do not respond to classic plaque control regimes, including 
establishment of appropriate oral hygiene, scale and polish, administration of chemical plaque control 
and elimination of plaque-retentive factors. In cases of non-resolving gingival inflammation the 
underlying cause is often of a systemic nature and careful examination of the oral cavity for other 
mucosal changes may reveal findings indicative of an underlying systemic condition (2). 
Prompt and accurate diagnosis of underlying systemic disease facilitates appropriate referral, 
investigation and management. It is also important to acknowledge that non-plaque-induced gingival 
lesions are often colonised and infected by oral bacteria whereby gingival and periodontal 
inflammation can additionally contribute to disease activity.  Thus, plaque control measures may 
ameliorate such lesions, however, they do not resolve until the systemic cause is targeted. The 
National Health Service (NHS) UK recommends that patients are seen for dental check-ups between 
every 3 to 24 months, depending on their oral health and needs. Because of the regular frequency of 
dental check-ups dental practitioners are in a unique position to facilitate an early diagnosis of 
systemic diseases, which can manifest in the oral cavity.  
This compendium focuses on non-plaque-induced and non-resolving lesions of the keratinised gingiva 
in dentate patients and aims to aid the practitioner to distinguish those systemic diseases that might 
be confused with plaque-induced gingival lesions. However, the authors have also included other 
systemic and related conditions, which commonly manifest to the gingivae, with the aim to provide the 
reader with a guide to establishing a differential diagnosis. The non-plaque-induced 
gingival/periodontal lesions described herein are also in accordance with the recently published 
Consensus Report of Workgroup 1 of the 2017 World Workshop on the Classification of Periodontal 
and Peri-Implant Diseases and Conditions (3). 
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The systemic underlying conditions along with oral clinical photographs, demographic data and clinical 
descriptions are presented in a summary table. In this article, part 1 of this compendium, we review 
immune mediated, autoinflammatory, and hereditary gingival lesions. In part 2 of the compendium we 
go on to review cancer related gingival lesions, infective and other causes of gingival inflammation. 
 
1. Anatomy and terminology 
1.1 Anatomy of the periodontium 
The periodontium consists of five types of tissues: 
1. Free gingiva, the tissue collar around the tooth, which forms the gingival crevice and is lined 
with epithelium, which is non-keratinised on the tooth-facing side and keratinised on the oral 
cavity-facing side. It is attached to the tooth at its base by the epithelial attachment, the 
junctional epithelium. The interdental free gingiva is referred to as the interdental papilla, 
which is knife-edged under healthy conditions. 
2. Attached gingiva, the tissue adjacent to the free gingiva, which is keratinised and firmly 
attached to the underlying bone structure. 
3. Alveolar mucosa, the area beyond the mucogingival junction, which is less firmly attached and 
non-keratinised. The mucogingival junction, a scalloped line, divides attached gingiva and 
alveolar mucosa. 
4. Alveolar bone consisting of dense cortical plates and cancellous bone as well as of the lamina 
dura, the wall of the socket.  
5. Periodontal ligament, which is attached to the lamina dura as well as to the cementum of the 
tooth, consists of apical, oblique, horizontal, alveolar crest and interradicular fibres as well as 
of blood and lymphatic vessels and nerves. 
 
1.2 Plaque-induced gingival lesions 
The oral cavity is habitat to several hundred microbial species including bacteria, viruses and fungi. 
The periodontium is a unique point of challenge in the body, as the tooth-bone interface constitutes a 
potential port of entry for microorganisms, whereas all other surfaces of the gastro-intestinal tract 
provide a closed epithelial layer, which eliminates colonising bacteria by epithelial shedding. Thus, if 
microorganisms on tooth surfaces are allowed to overgrow in the form of a biofilm (plaque), or 
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calculus, an inflammatory response of the periodontal and gingival tissues is initiated. Plaque-induced 
gingivitis is characterised by redness and swelling, but is fully reversible by eliminating biofilms from 
the tooth surfaces. Periodontitis is accompanied by pocket formation in the area of the junctional 
epithelium, in an attempt by the host immune cells to eliminate the biofilm by releasing toxic enzymes, 
proteins and reactive oxygen species. Nevertheless, the pocket environment provides excellent 
growth conditions for anaerobic bacteria, thereby driving inflammation and host-mediated tissue 
destruction. Only if biofilms and calculus are effectively removed from the pockets can tissue repair 
take place. An important distinguishing feature of plaque-induced gingival lesions is that, with the 
exception of necrotising and ulcerative forms, they are usually painless whereas non-plaque-induced 
gingival lesions are often symptomatic.  
 
1.3 Gingival enlargement 
Gingival enlargement or overgrowth (Figure 2) is encountered in a variety of systemic and related 
conditions including orofacial granulomatosis (see 2.3.1), granulomatosis with polyangiitis (see 2.4), 
neutropenia (see 2.6), plasma cell gingivitis (see 2.7), hereditary gingival fibromatosis and idiopathic 
gingival enlargement (see 3.1), drug-induced gingival enlargement (see Part 2: 6.1), scurvy (see Part 
2: 6.2) and mouth breathing (see Part 2: 7.1). It can also occur in plaque-induced gingivitis and 
periodontitis, especially in adolescents, pregnancy, and necrotising/ulcerative forms of these diseases.  
Distinguishing the cause can therefore be challenging but the medical history, extent of gingival 
swelling, presence of inflammation, and response to periodontal intervention can help in differentiating 
a diagnosis. An important distinguishing feature of some but not all of the systemic conditions in which 
gingival enlargement occurs is involvement of both the attached and unattached gingivae sometimes 
termed a “full-width“ or “full-thickness“ gingivitis. Involvement of the unattached gingivae can be seen 
in orofacial granulomatosis, plasma cell gingivitis, and polyangiitis with granulomatosis.  
 
1.4 Desquamative gingivitis 
Desquamative gingivitis (DG) (Figure 3) is a clinical descriptor rather than a diagnosis. Several 
mucocutaneous pathologies, including pemphigus vulgaris (see 2.1), pemphigoid and erythema 
multiforme (see 2.2), lichen planus and lupus erythematosus (see 2.5), allergic reactions (see 2.7) and 
drug-induced lesions (see Part 2: 6.1), can result in desquamative gingivitis. Widespread 
desquamation and/or erosion of the attached gingiva of the teeth is considered the chief characteristic 
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feature of desquamative gingivitis, it often affects the buccal and labial gingivae but can also occur in 
the palatal and lingual gingivae. Similarly to full-thickness gingival enlargement, DG is often but not 
always contiguous with involvement of the adjacent unattached gingivae and sulcus mucosa, which 
should alert the practitioner to the possibility of an alternative diagnosis. In addition to the underlying 
immune-inflammatory condition driving the desquamative gingivitis dental plaque is an important 
aggravating factor. It is often difficult to distinguish the cause of DG on purely clinical grounds and 
histology and immunologic testing are usually necessary to establish a diagnosis (4). 
 
2. Immune-mediated and autoinflammatory gingival lesions 
2.1 Pemphigus vulgaris  
Pemphigus vulgaris (PV) is an autoimmune blistering disease affecting the skin and mucous 
membranes (Figure 4). Oral lesions usually appear before skin lesions, and in many cases the oral 
cavity remains the only site affected. Autoantibodies are directed against desmosomes (epithelial 
adhesion proteins) that bind stratified squamous epithelial cells together (5). In common with other 
vesiculobullous diseases oral PV presents as shallow oral ulceration, preceded by fluid-filled blisters, 
which are rarely seen clinically due to their fragility. PV can affect any mucosal surfaces and 
desquamative gingivitis is a common feature. The preliminary diagnosis is based on the clinical 
presentation and confirmed by histology. PV can be life threatening, particularly in cases with 
extensive cutaneous involvement, by means of secondary infection leading to septicaemia. Early 
diagnosis and management can prevent this complication (6). However, treatment particularly with 
high dose corticosteroids can lead to significant and potentially life-threatening complications including 
diabetes, cardiovascular disease, peptic ulcers, adrenal insufficiency, and infection (7). 
 
2.2 Pemphigoid 
Pemphigoid is a group of vesiculobullous diseases and is a type of immune-mediated sub-epithelial 
blistering disease (IMSEBD). These diseases are mediated by a variety of autoantibodies that target 
the extracellular components that link the basement membrane to basal epithelial cells or to the 
lamina propria (8).  A number of IMSEBD can affect the oral cavity including dermatitis herpetiformis, 
toxic epidermal necrolysis / erythema multiforme, chronic bullous dermatosis of childhood, and 
pemphigoid variants. Pemphigoid variants include gestational pemphigoid, bullous pemphigoid, and 
mucous membrane pemphigoid (MMP). Additionally, acquired epidermolysis bullosa and linear IgA 
 7
disease are now thought to be variants of MMP (9, 10). Of the pemphigoid variants, mucous 
membrane pemphigoid (MMP) most commonly affects the oral cavity, with approximately 85 per cent 
of affected patients having oral involvement (Figure 5). When affecting the gingiva, mucous 
membrane pemphigoid commonly presents as desquamative gingivitis (11). Additionally MMP can 
affect a variety of extraoral sites including the ocular, nasal, nasopharyngeal, anogenital, laryngeal, 
and oesophageal mucosa and can also rarely involve the skin. Ocular involvement is of particular 
concern as this results in scarring which can eventually lead to blindness in the affected eye (12). 
Although this disorder has an unclear aetiology, pemphigoid-like lesions can occasionally be drug-
induced. There is no standard treatment protocol for the management of patients with MMP. The 
treatment strategies depend on the age of the patient, comorbidities, severity of the disease and the 
site involved, and may include the administration of corticosteroids, antimetabolites or antibiotics. 
Plaque control measures can play an important role in controlling oral inflammation in this condition 
(13). 
 
2.3 Orofacial granulomatosis and related conditions 
Orofacial granulomatous inflammation can occur in a variety of disparate conditions including 
inflammatory bowel disease, particularly Crohn‘s disease, sarcoidosis, Melkersson-Rosenthal 
syndrome, and tuberculosis and other mycobacterial infections. Cases can also occur without any 
apparent association with an underlying systemic disease in which case it might be thought of as 
idiopathic orofacial granulomatosis (14). Although the aetiopathogenesis of these conditions is varied 
or indeed unknown, we have grouped these disorders together based on their common clinical 
presentation to facilitate discussion.                         
 
2.3.1 (Idiopathic) orofacial granulomatosis                       
Orofacial granulomatosis (OFG) is a rare, granulomatous inflammatory disorder that is characterised 
by persistent enlargement of the soft oral and perioral tissues and has an unknown aetiology. 
Importantly, an onset of OFG during childhood may predict future development of Crohn’s disease 
(15). Affected patients typically present with persistent painless swelling of the lips (cheilitis 
granulomatosa), indurated tag-like lesions, cobblestoning, linear ulceration, and mucogingivitis. One of 
the characteristic features of the hyperplastic gingivitis seen in OFG is that it affects the attached and 
 8
unattached gingivae (full-thickness gingivitis). The mechanism of the enlargement is granulomatous 
inflammation. The best treatment of this condition and its prognosis are uncertain.  
Melkersson-Rosenthal syndrome, a neurological disorder, is characterised by orofacial swelling 
analogous to OFG, lower motor neurone facial palsy, and less commonly, fissured tongue. The facial 
palsy tends to be unilateral and may be indistinguishable from Bell's palsy. (16). 
 
2.3.2 Inflammatory bowel diseases  
Oral manifestations of the inflammatory bowel diseases Crohn’s disease and ulcerative colitis have 
been reported to affect up to 60% of the affected patients (17, 18). Crohn's disease is a polygenic 
autoinflammatory syndrome and which can affect any part of the gastrointestinal tract, including the 
mouth, although a majority of cases involve the terminal ileum. Orofacial granulomatosis is the 
commonest orofacial manifestation of this disease, but aphthous stomatitis is also occasionally seen in 
both CD and UC, however this is a non-specific finding.  
Pyostomatitis vegetans is most commonly encountered in patients with ulcerative colitis (UC) but has 
occasionally been reported in patients with CD. It is a chronic mucocutaneous ulcerative disorder 
consisting of multiple miliary white or yellow pustules with an erythematous and oedematous mucosal 
base (Figure 6). The pustules can rupture and coalesce to form linear or “snail-track” ulcers. The most 
frequently involved regions of the oral cavity are the labial gingiva and the labial and buccal mucosa, 
the tongue and floor of the mouth are rarely involved but it can affect almost all parts of the oral cavity 
(18, 19).  
 
2.3.3 Sarcoidosis 
Sarcoidosis is a chronic systemic disease of unknown aetiology and is characterised by an 
accumulation of epithelioid granulomas. Sarcoidosis affects multiple organs, especially the lungs, 
lymph nodes, skin and eyes. The salivary glands are frequently involved, sometimes resulting in 
xerostomia or bilateral parotid swelling, the combination of parotid swelling, fever, and anterior uveitis 
is known as uveoparotid fever or Heerfordt syndrome. Oral sarcoidosis is rare and the prevalence is 
unknown, while the treatment remains controversial and may range from oral glucocorticoids to 
surgical excision (20). Oral mucosal presentations are varied but include orofacial granulomatosis and 
localised erythematous swelling which can affect any oral mucosal site including the gingivae (21) 
(Figure 7). 
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2.4 Granulomatosis with polyangiitis 
Granulomatosis with polyangiitis, previously known as Wegener's granulomatosis, is a rare systemic 
disorder that can affect all areas of the body, including the oral cavity.  It is a form of vasculitis that 
affects small- and medium-size vessels in many organs. Those with the disease require long-term 
immunosuppression, as otherwise this conditions is lethal. The typical oral manifestations occur as 
gingival erosions and ulcerations, which often appear hyperplastic, leading to the typical clinical 
presentation of a “strawberry gingivitis”. Oral involvement in granulomatosis with polyangiitis has been 
reported in 10–62 per cent, but oral involvement as the first sign of the disease is found in only 2 per 
cent of cases (22) (Figure 8).  
 
2.5 Oral lichen planus 
Lichen planus is a mucocutaneous disorder, which commonly affects the skin and skin appendages 
(including scalp and nails), oral mucosa, and genitalia. Oesophageal, ocular, laryngeal, nasal, and 
urinary tract mucosa involvement have also rarely been reported. The epithelial damage is 
immunologically mediated by cytotoxic T-cells directed against basilar keratinocytes and results in 
vacuolar degeneration and lysis of basal cells. It is not a classical autoimmune disorder and is 
probably best typified as an inflammatory disease. Its aetiology is poorly understood but a variety of 
factors have been suggested including genetic, physiological, systemic disease, and hypersensitivity 
but there is currently no consensus (23). Oral lichen planus (OLP) is one of the most common oral 
mucosal diseases (24). Gingival involvement (desquamative gingivitis) is very frequently observed, 
and the disease is characterised by a high variability in clinical appearance and symptoms (Figure 9). 
There are several recognised clinical types including reticular, papular, plaque-like, atrophic, 
erosive/ulcerative, and rarely bullous variants. Additionally, oral lichenoid lesions including lichenoid 
contact lesions, lichenoid drug reactions, lichenoid lesions of graft versus host disease and lichenoid 
interface mucositis, seen in certain forms of lupus, can confuse the diagnosis. In common with many 
immune-inflammatory oral mucosal diseases, a synergy with periodontal inflammation exists, which 
can influence disease activity. Therefore patients with OLP require appropriate periodontal 
management, in combination with systemic evaluation, and topical or systemic 
immunosuppression/modulation (25).  
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2.6 Neutropenia 
 
The neutrophil is a polymorphonuclear immune defence cell and is the principal cell of the innate 
immune system. It therefore plays an important role in responding to infection through a diverse array 
of killing mechanisms including degranulation, respiratory burst resulting in the release of reactive 
oxygen species, and extrusion of their cytosol and nuclear chromatin as neutrophil extracellular traps. 
Additionally, as the first responder to microbial ingress the neutrophil helps orchestrate the immune-
inflammatory response to infection (26).  
As stated in section 1.2, the oral cavity is a unique environment in the body as there is a break in the 
integument at the tooth-bone / mucosa-tooth interface, which constitutes a potential direct entry port 
for microorganisms. As such the oral cavity has long been recognised as a site of particular relevance 
in individuals with immune defects, and this is commonly the case in those with neutropenia. 
Neutropenia is defined as a paucity or defective function of neutrophils, and there are several causes 
of neutropenia including primary forms (chronic benign neutropenia, cyclical neutropenia, and other 
congenital and familial neutropenias) and secondary forms (iatrogenic, aplastic anaemia, leukaemia, 
connective tissue disease, malignancies, and infections) all of which result in underproduction of 
neutrophils in the bone marrow. Neutropenia can also result from increased destruction of neutrophils 
(hypersplenism and immune neutropenia) and is rarely due to congenital immune defects (leukocyte 
adhesion deficiency, Chediak-Higashi syndrome, hyper-IgE syndrome, recurrent infection syndrome, 
and chronic granulomatous disease) (27, 28). All forms of neutropenia can result in oral mucosal 
pathology, primarily aphthous stomatitis and aggressive forms of gingivitis, which can be hyperplastic 
in nature (29, 30) (Figure 10).  
Treatment is varied and depends on the cause of the neutropenia but can include granulocyte-colony 
stimulating factor (G-CSF), prophylactic use of antibiotics and antifungals, interferon-gamma, 
allogeneic bone marrow transplantation, gene therapy, intravenous immunoglobulins, corticosteroids 
and other immunomodulatory or immunosuppressive therapies. 
 
2.7 Plasma cell gingivitis 
Plasma cell gingivitis (Figure 11) is a rare and benign condition, which is sometimes accompanied by 
cheilitis or glossitis ("plasma-cell gingivostomatitis"). It may represent a sub-type of plasma cell 
orofacial mucositis, which can be life threatening when it affects the airway and includes diverse 
entities such as Zoon’s balanitis / vulvitis, which affect the genital mucosa, but may also be a separate 
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disease entity. Other terms that have been used to describe this condition are idiopathic 
gingivostomatitis, atypical gingivostomatitis, allergic gingivostomatitis and plasmacytosis. The clinical 
presentation is that of erythematous mucosa with papillomatous, cobblestone, nodular, or 
granulomatous enlargement and it is histologically characterised by a dense plasma cell infiltrate (31). 
It may or may not involve the free gingival margin and can also be a localised lesion. Its aetiology is 
poorly understood but plasma cell gingivitis has been reported to be associated with hypersensitivity 
reactions to substances such as toothpaste and chewing gum ingredients, mint, pepper and cinnamon 
and in these cases resolution follows cessation of the offending allergen (32). However, beyond this 
there is currently no consensus on management of the disease. 
 
3. Hereditary conditions 
3.1 Hereditary gingival fibromatosis and idiopathic gingival hyperplasia 
Hereditary gingival fibromatosis is a rare, mostly autosomal dominant disease, which can develop as 
an isolated disorder or a feature of a syndrome. It is a benign oral condition characterised by slow and 
progressive enlargement of both maxillary and mandibular attached gingiva. It is commonly associated 
with hypertrichosis (excess hair growth) as well as with epilepsy and intellectual disability (33). A 
progressive fibrous enlargement of the gingiva is a feature of idiopathic hyperplasia/fibromatosis of the 
gingiva (Figure 12). Gingival fibromatosis may exist as an isolated abnormality or as part of a 
syndrome such as Laband syndrome (34). The exact cause of the disease is unknown, however, 
involvement of platelet-derived growth factor isoforms and its receptor as well as qualitative and 
quantitative differences in tumour growth factor-beta isoforms and receptor expression by fibroblasts 
have been suggested (35, 36).   
 
Conclusion 
In this article, the first part of this compendium, we have reviewed immune-mediated, 
autoinflammatory, and hereditary gingival lesions, supported by epidemiological data, clinical 
descriptions and photographs. Several of these systemic conditions can have a similar clinical 
presentation to periodontitis and gingivitis or exacerbate existing disease. On the other hand, plaque-
induced inflammation often worsens non plaque-induced conditions, which can make it more difficult 
to distinguish both. At the same time, dental practioners need to be aware that oral manifestations of 
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systemic diseases can impair oral hygiene abilities in affected patients. Those lesions which are 
accompanied by pain, are non-resolving or show a morphology atypical of a classic plaque-induced 
gingival lesions, should encourage dental practioners to refer their patient to a specialist unit. A full 
discussion of both part 1 and part 2 of this compendium is included in part 2: cancer related, infective, 
and other causes of gingival pathology. Readers are therefore referred to this paper.  
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Figure legends 
 
Figure 1. Plaque-induced gingival/periodontal diseases. A) Generalised chronic periodontitis with 
localised gingival swelling, recession formation, tooth loss and pathologic tooth migration. B) Plaque-
induced generalised gingivitis. 
 
Figure 2. Drug-induced gingival enlargement. Photograph courtesy of Mr Mutahir Rahman, 
Department of Periodontology, Birmingham Dental School and Hospital, Birmingham (UK). 
 
Figure 3. Desquamative gingivitis in a patient with lichen planus. 
 



Table 1. Overview of systemic and conditions and non-plaque related causes of gingival and periodontal lesions. All data are derived from the references indicated in 
the main text as well as from the Orphanet Rare Disease Collection: http://www.orphadata.org. Orphanet Report Series (Rare Disease Collection),  Prevalence and 
incidence of rare diseases: Bibilographic data: Orphanet, 2018. 
 
Figure Condition Demographics and incidence Image Clinical description 
4 Pemphigus vulgaris 
Prevalence: 18/100,000 (in 
Europe)  
 
Age group: usually in the 5th-
7th decades, although childhood 
onset forms have been 
described. 
 
Gender: F>M 
 
Main clinical presentation: ulcers, vesicles/bullae, mucosal 
erosions. Commonly presents as desquamative gingivitis 
 
Pain: moderate to severe 
 
Oral tissues involved: palate, buccal mucosae, lips 
5 Mucous membrane pemphigoid 
 
Prevalence: unknown 
 
Age group: usually in the 5th-
7th decades 
 
Gender: F>M 
 
Main clinical presentation: ulcers, vesicles/bullae, mucosal 
erosions. Commonly presents as desquamative gingivitis 
 
Pain: mild to severe depending on extent of involvement and 
disease activity 
 
Involvement of other oral tissues: palate, buccal mucosae, tongue 
(less common) 
6 
Oral 
manifestations of 
inflammatory 
bowel diseases 
Prevalence: 10-60% of those 
affected by IBD 
 
Age group: any 
 
Gender: M>F 
 
Main clinical presentation: indurated tag-like lesions, 
cobblestoning, mucogingivitis, edema, aphthous stomatitis, 
ulceration, pyostomatitis vegetans, hyperplasia  
 
Pain: orofacial granulomatosis: no; pyostomatitsis vegetans: 
variable; oral ulceration: moderate to severe 
 
Involvement of other oral tissues: buccal mucosa, lips (swelling 
and vertical fissuring), perioral tissues (dermatitis), floor of mouth 
(stag-horning)
7 Sarcoidosis 
 
Prevalence: 12.5/100,000 
(worldwide)  
 
Age group: any, but more 
prevalent in the 3rd to 6th 
decade 
 
Gender: M=F 
 
 
Main clinical presentation: firm swelling or nodular lesions 
 
Pain: no 
 
Involvement of other oral tissues: lips, hard and soft palate, 
buccal mucosa, tongue, tonsils, salivary glands 
8 Granulomatosis with polyangiitis 
Prevalence: 0.85/100,000 (in 
Europe)  
 
Age group: any 
 
Gender: F=M 
 
 
Main clinical presentation: granulomatous/papillary hyperplasia, 
erosion, ulceration, strawberry gingivitis 
 
Pain: no 
 
Involvement of other oral tissues: no 
 
 
9 Oral lichen planus 
 
Prevalence: 1,300/100,000 
(worldwide)  
   
Age group: between the 4th 
and 5th decade  
 
Gender: F>M 
 
Main clinical presentation: reticular white patterns (striae),  
keratotic plaques, atrophy, erosions/ulceration, papules,  
bullae (rare) 
 
Pain: mild to severe depending on extent and disease  
activity  
 
Involvement of other oral tissues: every area of the oral mucosa 
 
10 Neutropenia 
Prevalence: variable, 
depending on cause  
 
Age group: variable, depending 
on cause 
 
Gender: variable, depending on 
cause 
Main clinical presentation: pronounced gingivitis, often without 
visible plaque deposits. Recurrent aphthous stomatitis. 
 
Pain: variable – usually no  
 
Involvement of other oral tissues: all oral mucosal sites 
11 Plasma cell gingivitis 
Prevalence: unknown  
 
Age group: unknown 
 
Gender: unknown  
 
 
Main clinical presentation: erythema, edema, loss of stippling, 
papillary hyperplasia 
 
Pain: sometimes, occasionally accompanied by other sensations 
 
Involvement of other oral tissues: palate and buccal mucosa 
(occasionally) 
12 Hereditary gingival fibromatosis 
 
Prevalence: unknown 
 
Age group: any 
 
Gender: F=M 
 
Main clinical presentation: gingival enlargement 
 
Pain: no 
 
Involvement of other oral tissues: no 
 
 
Photograph courtesy of Mr Mutahir Rahman, Department of 
Periodontology, Birmingham Dental School and Hospital, 
Birmingham (UK) 
 
 
